Rakuten Medical

Rakuten Medical is a pharmaceutical company specializing in developing innovative cancer therapies. Their focus is on using their proprietary platform technology to create drugs that target cancer cells while sparing healthy cells. The company's lead drug, ASP-1929, is being studied for the treatment of various types of solid tumors, including head and neck cancer. Rakuten Medical was founded in 2008 and has since been dedicated to advancing the field of cancer therapy with a scientific and patient-centered approach.